MARKET

QNCX

QNCX

Quince
NASDAQ
0.5277
+0.3977
+305.92%
After Hours: 0.8500 +0.3223 +61.08% 19:59 02/10 EST
OPEN
0.2834
PREV CLOSE
0.1300
HIGH
0.6519
LOW
0.2459
VOLUME
1.59B
TURNOVER
--
52 WEEK HIGH
4.550
52 WEEK LOW
0.1251
MARKET CAP
29.38M
P/E (TTM)
-0.4327
1D
5D
1M
3M
1Y
5Y
1D
Quince Therapeutics, Spotify, S&P Global, Intel And Datadog: Why These 5 Stocks Are On Investors' Radars Today
Benzinga · 7h ago
Quince Therapeutics Stock Explodes 300% On Strategic Review
Benzinga · 12h ago
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
TipRanks · 14h ago
Gold Moves Lower; CVS Health Earnings Top Views
Benzinga · 15h ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 15h ago
Dow Surges Over 200 Points; Coca-Cola Posts Mixed Q4 Results
Benzinga · 17h ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/10/26
TipRanks · 19h ago
Why Is Quince Therapeutics Stock (QNCX) Up Today?
TipRanks · 19h ago
More
About QNCX
Quince Therapeutics, Inc. is a late-stage biotechnology company. The Company is engaged in unlocking the patient’s own biology to deliver life-changing therapeutics to those living with rare diseases. Its proprietary autologous intracellular drug encapsulation (AIDE) technology platform is a drug/device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The Company’s Phase III lead asset, eDSP, leverages its AIDE technology to encapsulate dexamethasone sodium phosphate (DSP) into a patient’s own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, Ataxia-Telangiectasia (A-T). Its AIDE technology is designed to allow for the chronic administration of drugs that have limitations due to toxicity, poor biodistribution, suboptimal pharmacokinetics, or immune response. The AIDE technology platform delivers a variety of therapeutics, ranging from small to large molecules drugs and biologics.

Webull offers Quince Therapeutics Inc stock information, including NASDAQ: QNCX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QNCX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QNCX stock methods without spending real money on the virtual paper trading platform.